Enoxaparine Injection is a low molecular weight heparin (LMWH) anticoagulant specifically formulated to prevent and treat venous thromboembolism by inhibiting blood clot formation. This injectable anticoagulant works by potentiating the activity of antithrombin III, which inactivates factor Xa and thrombin, effectively stopping existing blood clots from enlarging and preventing new clots from forming. It is primarily used in clinical settings for the prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of clot-related complications following surgeries or in patients with immobilization. The product is supplied as a sterile injection allowing for subcutaneous administration and is a critical pharmaceutical agent in cardiovascular and hematology therapeutic protocols. Enoxaparine Injection is essential for hospitals, clinics, and healthcare providers focused on managing thrombotic conditions efficiently and reducing life-threatening complications associated with blood clots.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Enoxaparine Sodium |
| Formulation | Sterile Injectable Solution |
| Therapeutic Class | Anticoagulant, Low Molecular Weight Heparin |
| Indications | Prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and other thromboembolic disorders |
| Mechanism of Action | Potentiates antithrombin III activity, inactivating factor Xa and thrombin |
| Route of Administration | Subcutaneous Injection |
| Clinical Use | Post-surgery thromboprophylaxis, immobilization-related clot prevention, treatment of existing clots |
| Packaging | Pre-filled syringes or vials |
| Storage Condition | Store at 2°C to 8°C, protect from light |
| Attributes | Description |
|---|---|
| Molecular Weight | Approximately 4,500 Daltons |
| Concentration | Typically 100 mg/mL or equivalent dosing as per prescription |
| Dosage Forms | Injection |
| pH | 4.5 to 5.5 |
| Shelf Life | 18 to 24 months under recommended storage |
| Preservatives | Preservative-free sterile formulation |
| Compatibility | Should not be mixed with other medications in the same syringe |
| Manufacturer Compliance | GMP certified manufacturer |
| Container Type | Glass prefilled syringes or sterile vials |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Enoxaparine Injection is primarily indicated for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
Enoxaparine Injection should be administered via subcutaneous injection, typically in the abdominal region, following prescribed dosing protocols to ensure optimal anticoagulant effect.
No, Enoxaparine Injection is a preservative-free sterile formulation and should not be mixed with other medications in the same syringe to maintain its stability and safety.
The product should be stored refrigerated at 2°C to 8°C and protected from light to maintain its potency and shelf life.
Yes, Enoxaparine Injection is widely used as thromboprophylaxis to prevent clot formation following surgeries, especially in patients at high risk of venous thromboembolism.
Country Of Origin: India
Enoxaparine Injection is an anticoagulant used to prevent and treat harmful blood clots. It stops the existing clots from getting any bigger and restricts the formation of any new clot. It is also helpful in the prevention of blood clots in veins, a condition called deep vein thrombosis, and pulmonary embolism.
